Your session is about to expire
← Back to Search
Neurofeedback for Depression
Study Summary
This trial tests if training brain activity can reduce symptoms of depression without medication.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I have been diagnosed with a psychotic, bipolar, or organic mental disorder.I have eye problems or trouble seeing even with glasses or contacts.I have been diagnosed with major depression and am currently feeling depressed.I have been diagnosed with major depression and am currently feeling depressed.I cannot fill out forms in English.I am between 18 and 55 years old.I am not on antidepressants or have been stable on them for at least 4 weeks.I do not have any serious or unstable health conditions.I am not currently taking medications like antipsychotics or stimulants that affect brain blood flow.
- Group 1: Amygdala real-time fMRI neurofeedback
- Group 2: Sham feedback
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Are the parameters of this clinical trial permissive to individuals 60 years and older?
"This trial is open to participants aged between 18 and 55 years old."
Are there any open spots in this medical research experiment?
"Per the details on clinicaltrials.gov, patient recruitment is not being conducted for this trial at present. The study was first shared on May 1st 2023 and last updated on January 18th of the same year. In contrast to this experiment, there are presently 1278 other trials looking for participants."
To whom is enrollment in this trial open?
"This research endeavour is seeking 200 participants, aged 18 to 55 and currently struggling with depression. To be eligible for the trial, patients must have a primary diagnosis of Major Depressive Disorder (MDD) and provide written consent prior to participation; additionally, those already taking antidepressants should remain on their medication as effective treatments are not being discontinued for study purposes."
Who else is applying?
What state do they live in?
What site did they apply to?
What portion of applicants met pre-screening criteria?
How many prior treatments have patients received?
Why did patients apply to this trial?
What questions have other patients asked about this trial?
Share this study with friends
Copy Link
Messenger